Rosetta Genomics Company
Rosetta Genomics discovers, develops and commercializes diagnostic tests for personalized medicine.
Technology:
Genetics/Genomics
Industry:
P4 Medicine
Headquarters:
United States
Investors Number:
4
Total Funding:
$143.8M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Secondary
Register and Claim Ownership